SpringWorks Therapeutics (SWTX) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
SWTX is expected to report earnings to fall 32.37% to -70 cents per share on May 01
Q1'25
Est.
$-0.70
Q4'24
Missed
by $0.39
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.58
Q1'24
Missed
by $0.01
The last earnings report on February 20 showed earnings per share of -103 cents, missing the estimate of -64 cents. With 3.54M shares outstanding, the current market capitalization sits at 4.37B.
a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer